Comparative evaluation of the effects of statins on human stem and cancer cells in vitro

Reproductive BioMedicine Online

Volumn 15, Issue 5, 2007, Pages 566-581

  Gauthaman, Kalamegam ^a   Richards, Mark ^a   Wong, John ^b   Bongso, Ariff ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Apoptosis; Cancer cells; Cancer genes; In vitro; Statins; Stem cells

Indexed keywords

COMPACTIN; FARNESYL DIPHOSPHATE; FLUOROURACIL; GERANYLGERANYL PYROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HT29; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME DUPLICATION; COLORECTAL CARCINOMA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; DRUG SENSITIVITY; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; GENE ACTIVITY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MONOTHERAPY; NICK END LABELING; OVARY CARCINOMA;

EID: 36448989350     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60390-2     Document Type: Article

References (44)

1. Agarwal B, Bhendwal S, Halmos B et al. 1999 Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clinical Cancer Research 5, 2223-2229.
2. Brickman JM, Burdon TG 2002 Pluripotency and tumorigenicity. Nature Genetics 32, 557-558.
3. Cheng AM, Saxton TM, Sakai R, et al. 1998 Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95, 793-803.
4. Dimitroulakos J, Ye LY, Benzaquen M et al. 2001 Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clinical Cancer Research 7, 158-167.
5. Draper JS, Smith K, Gokhale P et al. 2004 Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nature Biotechnology 22, 53-54.
6. Dvorak P, Dvorakova D, Hampl A 2006 Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Letters 580, 2869-2874.
7. Edwards PA, Ericsson J 1999 Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annual Review of Biochemistry 68, 157-185.
8. Enver T, Soneji S, Joshi C et al. 2005 Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Human Molecular Genetics 14, 3129-3140.
9. Gniadecki R 2004 Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochemical and Biophysical Research Communications 320, 165-169.
10. Hawk E, Viner JL 2005 Statins and cancer-beyond the 'one drug, one disease' model. New England Journal of Medicine 352, 2238-2239.
11. Jones CM, Simon-Chazottes D, Guenet JL et al. 1992 Isolation of Vgr-2, a novel member of the transforming growth factor-beta-related gene family. Molecular Endocrinology 6, 1961-1968.
12. Katano H, Pesnicak L, Cohen JI 2004 Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas. Proceedings of the National Academy of Science of the USA 101, 4960-4965.
13. Lee MH, Cho YS, Han YM 2007 Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Stem Cells 25, 1654-1663.
14. Li F 2005 Role of survivin and its splice variants in tumorigenesis. British Journal of Cancer 92, 212-216.
15. Li L, Patty M, Nicholas LK et al. 1999 Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s). Journal of Biological Chemistry 274, 33334-33340.
16. Li F, Ambrosini G, Chu EY et al. 1998 Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
17. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta (CT)) method. Methods 25, 402-408.
18. Marsden VS, O'Connor L, O'Reilly LA et al. 2002 Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419, 634-637.
19. Moyad MA, Merrick GS 2005 Statins and cholesterol lowering after a cancer diagnosis: why not? Urologic Oncology 23, 49-55.
20. O'Brien CA, Pollett A, Gallinger S et al. 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
21. Olie RA, Simoes-Wust AP, Baumann B et al. 2000 A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Research 60, 2805-2809.
22. Oltvai ZN, Milliman CL, Korsmeyer SJ 1993 Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
23. Pazzaglia S, Saran A, Pariset L et al. 1996 Sensitivity of C3H 10T1/2 cells to radiation-induced killing and neoplastic transformation as a function of cell cycle. International Journal of Radiation Biology 69, 57-65.
24. Plaia TW, Josephson R, Liu Y et al. 2006 Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. Stem Cells 24, 531-546.
25. Poynter IN, Gruber SB, Higgins PD et al. 2005 Statins and the risk of colorectal cancer. New England Journal of Medicine 352, 2184-2192.
26. Pyle AD, Lock LF, Donovan PJ 2006 Neurotrophins mediate human embryonic stem cell survival. Nature Biotechnology 24, 344-350.
27. Rao S, Porter DC, Chen X et al. 1999 Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proceedings of the National Academy of Science of the USA 96, 7797-7802.
28. Rattan R, Giri S, Singh AK et al. 2006 Rho/ROCK pathway as a target of tumor therapy. Journal of Neuroscience Research 83, 243-255.
29. Reya T, Morrison SJ, Clarke MF et al. 2001 Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
30. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. 2007 Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115.
31. Richards M, Tan SP, Tan JH et al. 2004 The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22, 51-64.
32. Sato N, Meijer L, Skaltsounis L et al. 2004 Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Medicine 10, 55-63.
33. Taipale J, Beachy PA 2001 The Hedgehog and Writ signaling pathways in cancer. Nature 411, 349-354.
34. Tamanoi F, Kato-Stankiewicz J, Jiang C et al. 2001 Farnesylated proteins and cell cycle progression. Journal of Cellular Biochemistry 37, 64-70.
35. Tanaka S, Mori M, Akiyoshi T et al. 1998 A novel variant of human Grb7 is associated with invasive esophageal carcinoma. Journal of Clinical Investigation 102, 821-827.
36. Ukomadu C, Dutta A 2003 p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. Journal of Biological Chemistry 278, 43596-43594.
37. van Vliet AK, van Thiel GC, Huisman RH et al. 1995 Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types. Biochimica et Biophysica Acta 1254, 105-111.
38. Varnum-Finney B, Xu L, Brashem-Stein C et al. 2000 Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nature Medicine 6, 1278-1281.
39. Vogelstein B, Kinzler KW 1992 p53 function and dysfunction. Cell 70, 523-526.
40. Wachtershauser A, Akoglu B, Stein J 2001 HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22, 1061-1067.
41. Weis M, Heeschen C, Glassford AJ et al. 2002 Statins have biphasic effects on angiogenesis. Circulation 105, 739-745.
42. Werner M, Sacher 1, Holieneggef M 2004 Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. British Journal of Pharmacology 143, 715-724,
43. Wong WW Tan MM, Xia Z et al. 2001 Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clinical Cancer Research 7, 2067-2075.
44. Zhang J, Wang X, Li M et al. 2006 NANOGP8 is a retrogene expressed in cancers. FEBS Journal 273, 1723-1730.